This study is testing a device called the ECHS AD Device, which uses pulsed electromagnetic fields, for people with mild to moderate Alzheimer's disease, Lewy body dementia, or vascular dementia. The goal is to see if this device can help slow down the disease's progression. You may be able to join if you are between 50 and 100 years old, have one of these types of dementia, and meet other specific health and education requirements. All participants will receive the active device and use it at home. Researchers will measure changes in your cognitive (thinking) abilities using a scale called the ADAS-Cog to see how well the treatment works. The current status of this study is unclear.

Study design

This is an open-label pilot study, meaning all 48 participants will know they are receiving the active ECHS AD Device. There is no comparison group receiving a placebo.

What's involved

You would use the device at home three times a day for 15 minutes over 120 days. Your cognitive abilities will be measured at several points during and after treatment.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 9 months after the 120-day treatment period ends.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.